ReviewF1000Research2019
Recent advances in therapies for eating disorders.
Review in F1000Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Eating disorder-related electrolyte abnormalities and adverse outcomes: A systematic review and meta-analysis.PloS one · 2026Pooled it
- Exploring MDMA assisted therapy in eating disorders: mechanisms, clinical evidence, and future directions.Journal of eating disorders · 2025Review
- Effectiveness of Jungian psychotherapy in supervised training settings.Research in psychotherapy (Milano) · 2025Article
- Effective Treatment Approaches for Eating Disorders in Children and Adolescents: A Review Article.Cureus · 2024Review
- The Impact of Chronic Stress Related to COVID-19 on Eating Behaviors and the Risk of Obesity in Children and Adolescents.Nutrients · 2023Review
- Atypical antipsychotic use does not impact weight gain for individuals with extreme anorexia nervosa: a retrospective case-control study.Journal of eating disorders · 2023Article
- Review
- Brain and gut microbiota disorders in the psychopathology of anorexia nervosa.Translational neuroscience · 2022Review
- Pervasive Refusal Syndrome: Three Case Reports-Autism as a Predisposing Factor and Gentle Coercion to Shorten Duration of Disorder?Case reports in psychiatry · 2022Article
- Association Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population.Frontiers in nutrition · 2022Article
- Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder.Eating and weight disorders : EWD · 2021Article
- Lessons Learned in Caring for Adolescents With Eating Disorders: The Singapore Experience.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2020Article
- Eating Disorders on College Campuses in the United States: Current Insight on Screening, Prevention, and Treatment.Current psychopharmacology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eating disorders are serious psychiatric illnesses with high rates of morbidity and mortality. Effective treatments have traditionally included behaviorally focused therapies as well as several medication strategies. Recent years have seen promising developments in these treatments, including additional support for family-based approaches for children and adolescents, new evidence for "third-wave" behavioral therapies, and new support for the use of lisdexamfetamine for binge eating disorder and olanzapine for anorexia nervosa. Case study and pilot data are beginning to show limited support for neuromodulatory interventions targeting brain regions thought to be involved in eating disorders. This review summarizes treatment developments over the last several years and points towards future directions for the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.